Lineage Cell Therapeutics, Inc. (LCTX)
1.225
+0.04
(+2.94%)
USD |
NYAM |
Jun 08, 16:00
1.225
0.00 (0.00%)
After-Hours: 16:43
Lineage Cell Therapeutics Shareholders Equity (Quarterly) : 53.88M for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Curis, Inc. | 12.71M |
| Halozyme Therapeutics, Inc. | 219.64M |
| Agenus, Inc. | -221.22M |
| Amgen, Inc. | 9.19B |
| BioCryst Pharmaceuticals, Inc. | -553.84M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 109.53M |
| Total Liabilities (Quarterly) | 56.84M |
| Debt to Equity Ratio | 0.0444 |
| Current Ratio | 6.893 |
| Net Debt Paydown Yield | 0.01% |